• レポートコード:GIR201105692 • 出版社/出版日:GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、107ページ • 納品方法:Eメール • 産業分類:医薬品・医療 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、鼻インフルエンザワクチンの世界市場を調査対象にし、鼻インフルエンザワクチンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(三価インフルエンザワクチン、四価インフルエンザワクチン)、用途別分析(子供、大人)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報:AstraZeneca ・メーカー別販売量、売上、市場シェア ・鼻インフルエンザワクチンの地域別市場分析 ・鼻インフルエンザワクチンの北米市場規模2015-2020:アメリカ、カナダ、メキシコ ・鼻インフルエンザワクチンのヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど ・鼻インフルエンザワクチンのアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど ・鼻インフルエンザワクチンの南米市場規模2015-2020:ブラジル、アルゼンチンなど ・鼻インフルエンザワクチンの中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど ・鼻インフルエンザワクチンの種類別市場規模2015-2020:三価インフルエンザワクチン、四価インフルエンザワクチン ・鼻インフルエンザワクチンの用途別市場規模2015-2020:子供、大人 ・鼻インフルエンザワクチンの世界市場予測2021-2025:地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Nasal Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Nasal Flu Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Nasal Flu Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nasal Flu Vaccine market has been segmented into
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
By Application, Nasal Flu Vaccine has been segmented into:
Child
Adult
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nasal Flu Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Nasal Flu Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nasal Flu Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Nasal Flu Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Nasal Flu Vaccine Market Share Analysis
Nasal Flu Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nasal Flu Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nasal Flu Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Nasal Flu Vaccine are:
AstraZeneca
Among other players domestic and global, Nasal Flu Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nasal Flu Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nasal Flu Vaccine, with price, sales, revenue and global market share of Nasal Flu Vaccine in 2018 and 2019.
Chapter 3, the Nasal Flu Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nasal Flu Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nasal Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nasal Flu Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Nasal Flu Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nasal Flu Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Trivalent Flu Vaccine
1.2.3 Quadrivalent Flu Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Nasal Flu Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Child
1.3.3 Adult
1.4 Overview of Global Nasal Flu Vaccine Market
1.4.1 Global Nasal Flu Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Nasal Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nasal Flu Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nasal Flu Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nasal Flu Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Nasal Flu Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nasal Flu Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Nasal Flu Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nasal Flu Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nasal Flu Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Nasal Flu Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Nasal Flu Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nasal Flu Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Nasal Flu Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nasal Flu Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
6.4 France Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nasal Flu Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nasal Flu Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nasal Flu Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
7.5 India Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nasal Flu Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Nasal Flu Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Nasal Flu Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nasal Flu Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nasal Flu Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nasal Flu Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nasal Flu Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Nasal Flu Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Nasal Flu Vaccine Price by Type (2015-2020)
11 Global Nasal Flu Vaccine Market Segment by Application
11.1 Global Nasal Flu Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Nasal Flu Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Nasal Flu Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nasal Flu Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Nasal Flu Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Nasal Flu Vaccine Market Forecast (2021-2025)
12.2.2 Europe Nasal Flu Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nasal Flu Vaccine Market Forecast (2021-2025)
12.2.4 South America Nasal Flu Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nasal Flu Vaccine Market Forecast (2021-2025)
12.3 Nasal Flu Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Nasal Flu Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Nasal Flu Vaccine Market Share Forecast by Type (2021-2025)
12.4 Nasal Flu Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Nasal Flu Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Nasal Flu Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Nasal Flu Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nasal Flu Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nasal Flu Vaccine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Nasal Flu Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Nasal Flu Vaccine Major Business
Table 10. AstraZeneca Nasal Flu Vaccine Total Revenue (USD Million) (2018-2019)
Table 11. AstraZeneca SWOT Analysis
Table 12. AstraZeneca Nasal Flu Vaccine Product and Services
Table 13. AstraZeneca Nasal Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Global Nasal Flu Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 15. Global Nasal Flu Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 16. Global Nasal Flu Vaccine Sales by Regions (2015-2020) (K Units)
Table 17. Global Nasal Flu Vaccine Sales Market Share by Regions (2015-2020)
Table 18. Global Nasal Flu Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 19. North America Nasal Flu Vaccine Sales by Countries (2015-2020) (K Units)
Table 20. North America Nasal Flu Vaccine Sales Market Share by Countries (2015-2020)
Table 21. North America Nasal Flu Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 22. North America Nasal Flu Vaccine Revenue Market Share by Countries (2015-2020)
Table 23. Europe Nasal Flu Vaccine Sales by Countries (2015-2020) (K Units)
Table 24. Europe Nasal Flu Vaccine Sales Market Share by Countries (2015-2020)
Table 25. Europe Nasal Flu Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 26. Asia-Pacific Nasal Flu Vaccine Sales by Regions (2015-2020) (K Units)
Table 27. Asia-Pacific Nasal Flu Vaccine Sales Market Share by Regions (2015-2020)
Table 28. Asia-Pacific Nasal Flu Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 29. South America Nasal Flu Vaccine Sales by Countries (2015-2020) (K Units)
Table 30. South America Nasal Flu Vaccine Sales Market Share by Countries (2015-2020)
Table 31. South America Nasal Flu Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 32. South America Nasal Flu Vaccine Revenue Market Share by Countries (2015-2020)
Table 33. Middle East & Africa Nasal Flu Vaccine Sales by Countries (2015-2020) (K Units)
Table 34. Middle East & Africa Nasal Flu Vaccine Sales Market Share by Countries (2015-2020)
Table 35. Middle East & Africa Nasal Flu Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 36. Middle East & Africa Nasal Flu Vaccine Revenue Market Share by Countries (2015-2020)
Table 37. Global Nasal Flu Vaccine Sales by Type (2015-2020) (K Units)
Table 38. Global Nasal Flu Vaccine Sales Share by Type (2015-2020)
Table 39. Global Nasal Flu Vaccine Revenue by Type (2015-2020) (USD Million)
Table 40. Global Nasal Flu Vaccine Revenue Share by Type (2015-2020)
Table 41. Global Nasal Flu Vaccine Sales by Application (2015-2020) (K Units)
Table 42. Global Nasal Flu Vaccine Sales Share by Application (2015-2020)
Table 43. Global Nasal Flu Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 44. Global Nasal Flu Vaccine Market Share Forecast by Regions (2021-2025)
Table 45. Global Nasal Flu Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 46. Global Nasal Flu Vaccine Market Share Forecast by Type (2021-2025)
Table 47. Global Nasal Flu Vaccine Sales Forecast by Application (2021-2025)
Table 48. Global Nasal Flu Vaccine Market Share Forecast by Application (2021-2025)
Table 49. Direct Channel Pros & Cons
Table 50. Indirect Channel Pros & Cons
Table 51. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nasal Flu Vaccine Picture
Figure 2. Global Sales Market Share of Nasal Flu Vaccine by Type in 2019
Figure 3. Trivalent Flu Vaccine Picture
Figure 4. Quadrivalent Flu Vaccine Picture
Figure 5. Nasal Flu Vaccine Sales Market Share by Application in 2019
Figure 6. Child Picture
Figure 7. Adult Picture
Figure 8. Global Nasal Flu Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Nasal Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Nasal Flu Vaccine Sales Market Share by Manufacturer in 2019
Figure 29. Global Nasal Flu Vaccine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Nasal Flu Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Nasal Flu Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Nasal Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Nasal Flu Vaccine Revenue Market Share by Regions (2015-2020)
Figure 36. Global Nasal Flu Vaccine Revenue Market Share by Regions in 2018
Figure 37. North America Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
Figure 38. Europe Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
Figure 40. South America Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Nasal Flu Vaccine Sales and Growth Rate (2015-2020)
Figure 42. North America Nasal Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Nasal Flu Vaccine Sales Market Share by Countries (2015-2020)
Figure 44. North America Nasal Flu Vaccine Sales Market Share by Countries in 2018
Figure 45. North America Nasal Flu Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Nasal Flu Vaccine Revenue Market Share by Countries in 2018
Figure 47. United States Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Nasal Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Nasal Flu Vaccine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Nasal Flu Vaccine Revenue Market Share by Countries in 2019
Figure 53. Germany Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Nasal Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Nasal Flu Vaccine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Nasal Flu Vaccine Revenue Market Share by Regions 2019
Figure 61. China Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Nasal Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Nasal Flu Vaccine Sales Market Share by Countries in 2019
Figure 68. South America Nasal Flu Vaccine Revenue Market Share by Countries in 2019
Figure 69. Brazil Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Nasal Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Nasal Flu Vaccine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Nasal Flu Vaccine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Nasal Flu Vaccine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Nasal Flu Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Nasal Flu Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Nasal Flu Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Nasal Flu Vaccine Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Nasal Flu Vaccine Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Nasal Flu Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Nasal Flu Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Nasal Flu Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel